Dart Drops $716M on Evolution, NVIDIA Director Sells Out

Kenneth Bryan Dart, the main shareholder of EVO, disclosed a purchase of 10.06 million shares in Evolution AB worth roughly $716 million. The filings landed on 26 August. Dart paid an average of around SEK 690 to 695 per share and now holds approximately 59.8 million shares, equal to about 31% of the company.

The scale of the buy stands out. Dart made two separate open-market purchases on 21 and 24 July, then filed both together five weeks later. That delay is legal but unusual. The combined stake, worth over $4 billion at current prices, makes him by far the largest single investor in the Swedish gaming group.

At NVIDIA, independent director Mark Stevens filed sales totalling roughly $411 million across 1 September and 2 September. The trades were executed at prices between $220 and $226 per share. Stevens is a venture capitalist and long-time NVIDIA board member. ORTEX data does not flag these as pre-planned 10b5-1 sales, so they carry a stronger signal than typical executive disposals.

Separately, Fosun Pharma Industrial filed two sales of Gland Pharma stock worth a combined $296 million, reported on 1 and 8 September. Fosun is a promoter-group entity, and cutting such a large stake in an Indian pharmaceuticals business is a notable change in posture for the Chinese healthcare conglomerate.

The insider data available runs to early September. More recent filings may have emerged since then.